P16/Ki-67 Immunostaining in the Triage of Postmenopausal Women With Low-Grade Cytology Results

被引:5
|
作者
Dovnik, Andraz [1 ]
Repse Fokter, Alenka [2 ]
机构
[1] Univ Med Ctr Maribor, Univ Clin Gynecol & Perinatol, Ljubljanska 5, SI-2000 Maribor, Slovenia
[2] Gen Hosp Celje, Dept Pathol & Cytol, Celje, Slovenia
关键词
cervical cytology; p16; Ki-67; immunostaining; postmenopausal; high-grade cervical disease; DUAL-STAINED CYTOLOGY; CERVICAL-CANCER PRECURSORS; ATYPICAL SQUAMOUS-CELLS; HPV-POSITIVE WOMEN; SMEARS;
D O I
10.1097/LGT.0000000000000539
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective The interpretation of postmenopausal smears and the gynecological treatment of these patients can often be difficult. The objective of this study was to assess the performance of p16/Ki-67 dual-stained cytology as a triage of atypical squamous cells of undetermined significance and low-grade intraepithelial lesion cytology results in postmenopausal women. Methods All consecutive atypical squamous cells of undetermined significance and low-grade intraepithelial lesion smears in 1-year period were collected and p16/Ki-67 immunostaining was performed retrospectively. The results were compared with histology results or long-term cytology follow-up in cases with no biopsy. Results The sensitivity of p16/Ki-67 immunostaining for the detection of cervical intraepithelial neoplasia (CIN) 2 and CIN 3 was 57.1% and 85.0%, respectively. The specificity for the detection of CIN 2 was 94.3% and CIN 3 92.4%. Negative predictive values for the detection of CIN 2 and CIN 3 were 96.3% and 99.6%, respectively. Conclusions Dual p16/Ki-67 immunostaining is a useful additional method in postmenopausal patients with low-grade cytology. Considering the high specificity and negative predictive value in our study, we believe that it could be helpful in avoiding unnecessary referrals to colposcopy and thus reduce the cost of the program.
引用
收藏
页码:235 / 237
页数:3
相关论文
共 50 条
  • [21] The p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions
    Magkana, Maria
    Mentzelopoulou, Panagiota
    Magkana, Ekaterini
    Pampanos, Andreas
    Daskalakis, Georgios
    Domali, Ekaterini
    Rodolakis, Alexandros
    Pappa, Kalliopi
    PLOS ONE, 2021, 16 (06):
  • [22] Application of p16/Ki-67 dual-staining cytology in cervical cancers
    Yu, Li
    Fei, Lingyan
    Liu, Xubin
    Pi, Xufang
    Wang, Liantang
    Chen, Shangwu
    JOURNAL OF CANCER, 2019, 10 (12): : 2654 - 2660
  • [23] Evaluation of the clinical performance of p16/Ki-67 dual-staining cytology for cervical lesion detection in premenopausal and postmenopausal Chinese women
    Dai, Yu
    Chen, Tingting
    Li, Xinyue
    Zhang, Changning
    Li, Tingyuan
    Zhao, Yuqian
    Wang, Yakun
    Chen, Simiao
    Yu, Lulu
    Jiang, Mingyue
    Wu, Zeni
    Yang, Jinghong
    Chen, Wen
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10645 - 10658
  • [24] Interpretation of p16INK4a/Ki-67 Dual Immunostaining for the Triage of Human Papillomavirus-Positive Women by Experts and Nonexperts in Cervical Cytology
    Allia, Elena
    Ronco, Guglielmo
    Coccia, Anna
    Luparia, Patrizia
    Macri, Luigia
    Fiorito, Corinna
    Maletta, Francesca
    Deambrogio, Cristina
    Tunesi, Sara
    De Marco, Laura
    Gillio-Tos, Anna
    Sapino, Anna
    Ghiringhello, Bruno
    CANCER CYTOPATHOLOGY, 2015, 123 (04) : 212 - 218
  • [25] Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology
    Petry, K. Ulrich
    Schmidt, Dietmar
    Scherbring, Sarah
    Luyten, Alexander
    Reinecke-Luethge, Axel
    Bergeron, Christine
    Kommoss, Friedrich
    Loening, Thomas
    Ordi, Jaume
    Regauer, Sigrid
    Ridder, Ruediger
    GYNECOLOGIC ONCOLOGY, 2011, 121 (03) : 505 - 509
  • [26] Ki-67: A prognostic factor for low-grade glioma?
    Fisher, BJ
    Naumova, E
    Leighton, CC
    Naumov, GN
    Kerklviet, N
    Fortin, D
    Macdonald, DR
    Cairncross, JG
    Bauman, GS
    Stitt, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (04): : 996 - 1001
  • [27] The Role of p16/Ki-67 Immunostaining, hTERC Amplification and Fibronectin in Predicting Cervical Cancer Progression: A Systematic Review
    Voidazan, Septimiu Toader
    Dianzani, Caterina
    Husariu, Madalina Aurelia
    Gered, Biborka
    Turdean, Sabin Gligore
    Uzun, Cosmina Cristina
    Kovacs, Zsolt
    Rozsnyai, Florin Francisc
    Neagu, Nicoleta
    BIOLOGY-BASEL, 2022, 11 (07):
  • [28] Evaluation of Biomarkers p16/Ki-67 in Cervical Cytology for Diagnosis of Cervical Intraepithelial Neoplasia
    Shalini Rajaram
    Sathija Puthiya kulap
    Bindiya Gupta
    V. K. Arora
    Alok C. Bharti
    Neerja Goel
    Indian Journal of Gynecologic Oncology, 2019, 17
  • [29] HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions
    Vrdoljak-Mozetic, D.
    Krasevic, M.
    Ostojic, D. Versa
    Stemberger-Papic, S.
    Rubesa-Mihaljevic, R.
    Bubonja-Sonje, M.
    CYTOPATHOLOGY, 2015, 26 (01) : 10 - 18
  • [30] Meta-analysis on the performance of p16/Ki-67 dual immunostaining in detecting high-grade cervical intraepithelial neoplasm
    Sun, Meng
    Shen, Yang
    Ren, Mu-Lan
    Dong, Yi-Min
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S587 - S593